Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply
- PMID: 38591799
- DOI: 10.1111/apt.17966
Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply
Comment on
-
Editorial: Recompensation in PBC is good. But is it good enough?Aliment Pharmacol Ther. 2024 May;59(9):1144-1145. doi: 10.1111/apt.17924. Aliment Pharmacol Ther. 2024. PMID: 38591801 No abstract available.
References
REFERENCES
-
- Verhelst X. Editorial: recompensation in PBC is good. But is it good enough? Aliment Pharmacol Ther. 2024;59:1144–1145.
-
- Hofer BS, Simbrunner B, Burghart L, Halilbasic E, Petrenko O, Mandorfer M, et al. Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis. Aliment Pharmacol Ther. 2024;59:962–972.
-
- de Franchis R, Bosch J, Garcia‐Tsao G, Reiberger T, Ripoll C, Baveno VII Faculty. Baveno VII – renewing consensus in portal hypertension. J Hepatol. 2022;76:959–974.
-
- Harms MH, van Buuren HR, Corpechot C, Thorburn D, Janssen HLA, Lindor KD, et al. Ursodeoxycholic acid therapy and liver transplant‐free survival in patients with primary biliary cholangitis. J Hepatol. 2019;71:357–365.
-
- Hofer BS, Simbrunner B, Hartl L, Jachs M, Balcar L, Paternostro R, et al. Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol‐related cirrhosis. Liver Int. 2023;43:2220–2231.
Publication types
LinkOut - more resources
Full Text Sources